![](/img/cover-not-exists.png)
146: Therapeutic advantage of concurrent chemoradiotherapy with 55 Gy/20 fractions with cisplatinum and vinorelbine assessed by comparing control rates predicted by radio-biological (Biosuite) software and clinical results
Maguire, J., Uzan, J., Kelly, V.Volume:
87
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/S0169-5002(15)50140-2
Date:
January, 2015
File:
PDF, 45 KB
english, 2015